Current Events Current Affairs Analysis
Ranchi is set to become the first district in Jharkhand to implement a large-scale campaign for the screening and management of non-alcoholic fatty liver disease.
NAFLD, now known as Metabolic dysfunction-associated steatotic liver disease (MASLD), is the term for a range of conditions caused by a build-up of fat in the liver.
This buildup of fat is not caused by heavy alcohol use. When heavy alcohol use causes fat to build up in the liver, this condition is called alcohol-associated liver disease.
Early-stage NAFLD does not usually cause any harm, but it can lead to serious liver damage, including cirrhosis, if it gets worse.
Having high levels of fat in your liver is also associated with an increased risk of serious health problems, such as diabetes, high blood pressure and kidney disease.
Nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH) are types of NAFLD.
NASH is the severe form, which can cause cirrhosis and liver failure. It can also cause liver cancer.
NAFLD can affect people of any age, including children.
Treatment:
iThere's currently no specific medication for NAFLD.
iiDoctors recommend weight loss to treat NAFLD.
iiiWeight loss can reduce fat, inflammation, and fibrosis in the liver.
ivTreatment may also be recommended for associated conditions (high blood pressure, diabetes, and cholesterol) or complications.